Phase II trial of Nimustine (ACNU; 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride) in patients with small cell carcinoma of the lung after failure on combination chemotherapy
Keyword(s):
Phase Ii
◽
1982 ◽
Vol 5
(1)
◽
pp. 49-52
◽
1983 ◽
Vol 6
(2)
◽
pp. 171-174
◽
1994 ◽
Vol 30
(2)
◽
pp. 158-161
◽